Brand Intelligence Graph
Company Overview
About Pacific Biosciences
Pacific Biosciences (PacBio) was founded in 2004 in Menlo Park, California and pioneered single-molecule real-time (SMRT) sequencing technology, enabling long-read DNA sequencing that can span tens of thousands of base pairs per read. This capability is essential for resolving complex genomic regions—structural variants, repeat expansions, methylation patterns, and full-length transcripts—that short-read platforms like Illumina cannot accurately assemble.
Business Model & Competitive Advantage
PacBio's Revio system, launched in 2023, offers a dramatic improvement in throughput and cost efficiency over prior instruments, targeting both research and clinical sequencing laboratories. Key applications include rare disease diagnosis, pharmacogenomics, plant and animal genomics, and clinical oncology. The company guides to $150–$170 million in FY2025 revenue with gross margins exceeding 40% and a path to cash flow breakeven by 2027.
Competitive Landscape 2025–2026
PacBio competes primarily with Oxford Nanopore Technologies in the long-read segment, together driving adoption of long-read sequencing for comprehensive genome assembly and clinical applications. The company is expanding its high-accuracy (HiFi) chemistry and developing Onso, a short-read system, to capture a broader share of the sequencing market. With approximately $260 million in cash, PacBio is well-positioned to scale its clinical business.
Key Differentiators
Growth Stage
Pacific Biosciences has achieved $170M in revenue, demonstrating strong product-market fit.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Oxford Nanopore Technologies
Illumina
Illumina was founded in 1998 in San Diego and has grown into the undisputed leader in next-generation sequencing (NGS), with approximately 80% global market share across research and clinical applicat
10x Genomics
10x Genomics was founded in 2012 in Pleasanton, California by Serge Saxonov, Ben Hindson, and Kevin Ness. The company developed the Chromium platform for single-cell RNA sequencing (scRNA-seq), enabli
Schrödinger
Schrödinger was founded in 1990 by Richard Friesner and David Pearlman in New York City, building physics-based computational methods for molecular simulation. For over 30 years the company has develo
Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m
Florence Healthcare
Florence Healthcare is the dominant software platform for clinical trial site enablement, providing digital tools that connect trial sites, sponsors, and contract research organizations (CROs) to stre
Compare Pacific Biosciences with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Pacific Biosciences? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Pacific Biosciences Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Pacific Biosciences vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →